CVS Health Cash and Equivalents Trend

CVS -- USA Stock  

Fiscal Quarter End: December 31, 2019  

This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 132.3 B, Consolidated Income of 4.2 B or Cost of Revenue of 106.2 B, but also many exotic indicators such as Interest Coverage of 7.0765, Long Term Debt to Equity of 0.86 or Calculated Tax Rate of 95.2946. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.

CVS Health Cash and Equivalents Marginal Breakdown

Showing smoothed Cash and Equivalents of CVS Health Corporation with missing and latest data points interpolated. A component of [Assets] representing the amount of currency on hand as well as demand deposits with banks or financial institutions.
View

8.53 B

          10 Years Trend
Increasing
Stable
 Cash and Equivalents 
      Timeline 

CVS Health Regression Statistics

Arithmetic Mean 2,269,072,727
Geometric Mean 1,789,053,328
Coefficient Of Variation 98.19
Mean Deviation 1,463,791,735
Median 1,352,000,000
Standard Deviation 2,228,035,336
Range 7,177,999,999
R Value 0.31
R Squared 0.1
Significance 0.35
Slope 210,601,818

CVS Health Cash and Equivalents Over Time

2010  1,352,000,000 
2018  1,554,800,000 
2019  8,529,999,999 

Other Fundumenentals of CVS Health

Search macroaxis.com